- Report
- October 2021
- 178 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- June 2022
- 146 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- April 2023
- 112 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- October 2022
- 110 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- April 2023
- 180 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- October 2023
- 90 Pages
India
From €3378EUR$3,500USD£2,898GBP
- Report
- July 2022
- 155 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- March 2021
- 149 Pages
Global
From €6708EUR$6,950USD£5,754GBP
- Report
- August 2022
United States
From €1872EUR$1,940USD£1,606GBP
- Report
- August 2021
Europe
From €3301EUR$3,420USD£2,832GBP
- Report
- August 2021
Global
From €3851EUR$3,990USD£3,304GBP
- Report
- March 2022
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- February 2019
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- March 2021
Global
From €4102EUR$4,250USD£3,519GBP
- Report
- October 2018
- 107 Pages
Global
From €4295EUR$4,450USD£3,684GBP
- Report
- March 2022
- 157 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Clinical Trials
- June 2020
- 109 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Clinical Trials
- May 2020
- 226 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- January 2024
- 80 Pages
United Kingdom
From €2505EUR$2,595USD£2,149GBP
Uveitis is a medical condition that affects the uvea, the middle layer of the eye. It is characterized by inflammation of the uvea, which can lead to vision loss and other complications. In the context of optical, uveitis is a major cause of vision loss and can be treated with a variety of treatments, including topical and systemic medications, laser treatments, and surgery.
Uveitis is a growing market in the optical industry, as it is a common cause of vision loss and can be treated with a variety of treatments. Companies in the uveitis market include Bausch + Lomb, Novartis, Allergan, and Santen Pharmaceuticals. These companies offer a range of treatments for uveitis, including topical and systemic medications, laser treatments, and surgery. Show Less Read more